Immunology

Catch up on EADV 2026 poster highlights: real-world dupilumab data in atopic dermatitis, bullous pemphigoid and prurigo nodularis. For healthcare professionals.

Explores the connections between Type 2 inflammatory diseases and the opportunities to improve patient outcomes through earlier, targeted intervention

Access ERS 2026 Congress highlights on severe asthma, COPD, and biologic therapies. Real-world evidence and clinical insights for HCPs

Missed this webinar? You can now watch the recording of the webinar to learn about the role of biologics in severe asthma and COPD¹ through real-world clinical cases presented by a panel of expert clinicians.

Missed the live session? You can now watch the Advanced Airways Collaborative webinar on-demand.​

Explore ATS 2026 key sessions on dupilumab, COPD biologics, FeNO biomarkers, and asthma remission. Real-world evidence for HCPs

AAD 2026 post-congress: Complete systemic therapy update. Multi-indication clinical data for inflammatory dermatological conditions.

The programme brought together international and local experts to discuss the evolving understanding of Type 2 inflammation in atopic dermatitis, with a focus on IL-4 and IL-13, disease modification, and the importance of early intervention across different patient populations.